logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

WuXi PharmaTech (Cayman) Inc. (02359.HK) will distribute an interim dividend of HK$3.5 per 10 shares on September 26th.

date
30/07/2025
Zhtng Cijng APP news: WuXi Biologics (02359.HK) has announced that the company will distribute a mid-year dividend of 3.5 yuan for every 10 shares on September 26, 2025.
Latest
3 m ago
Putai Lai: Shareholder Ningbo Shengyue continues to pledge renewal of 3.44% of the company's shares.
3 m ago
Porsche CFO: Layoffs will be carried out, cost-saving measures will be fully implemented.
3 m ago
Mercedes CEO: Zero tariffs on exports to the EU by the US are more beneficial than harmful to the German automotive industry because we are the largest exporter of cars to the US.
3 m ago
Nissan CEO Espinosa: Our integration work for manufacturing layout is progressing as planned and will be completed by the 2027 fiscal year.
4 m ago
A residential land in Longhua District of Shenzhen was transacted at a base price of 1.906 billion yuan.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.